Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96428375 | 9642837 | 5 | F | 201605 | 20160815 | 20131024 | 20160819 | EXP | PHHY2013BR114734 | NOVARTIS | 61.33 | YR | F | Y | 55.00000 | KG | 20160819 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96428375 | 9642837 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, EVERY 28 DAYS | 21008 | 20 | MG | VIAL | /month | ||||||
| 96428375 | 9642837 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO, EVERY 28 DAYS | 21008 | 30 | MG | VIAL | /month | ||||||
| 96428375 | 9642837 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 10 MG, UNK | 21008 | 10 | MG | VIAL | |||||||
| 96428375 | 9642837 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO, EVERY 28 DAYS | 21008 | 30 | MG | VIAL | /month | ||||||
| 96428375 | 9642837 | 5 | C | BROMOCRIPTINE | BROMOCRIPTINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 96428375 | 9642837 | 6 | C | CABERGOLINE. | CABERGOLINE | 1 | Oral | 4 DF, QD | 0 | 4 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96428375 | 9642837 | 1 | Acromegaly |
| 96428375 | 9642837 | 5 | Blood prolactin increased |
| 96428375 | 9642837 | 6 | Blood prolactin increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96428375 | 9642837 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96428375 | 9642837 | Benign breast neoplasm | |
| 96428375 | 9642837 | Blood growth hormone increased | |
| 96428375 | 9642837 | Cardiomegaly | |
| 96428375 | 9642837 | Dyspnoea | |
| 96428375 | 9642837 | Galactorrhoea | |
| 96428375 | 9642837 | General physical health deterioration | |
| 96428375 | 9642837 | Inguinal hernia | |
| 96428375 | 9642837 | Lung disorder | |
| 96428375 | 9642837 | Mammary duct ectasia | |
| 96428375 | 9642837 | Nasal discomfort | |
| 96428375 | 9642837 | Nasal obstruction | |
| 96428375 | 9642837 | Neoplasm progression | |
| 96428375 | 9642837 | Rhinitis | |
| 96428375 | 9642837 | Therapy non-responder | |
| 96428375 | 9642837 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96428375 | 9642837 | 1 | 20091029 | 0 | ||
| 96428375 | 9642837 | 2 | 20091126 | 0 |